Dupilumab for treating moderate to severe prurigo nodularis

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 4.62 MB)

  Published:

  13 March 2024

• Final draft guidance committee papers (PDF 1.84 MB)

  Published:

  13 March 2024